Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Study protocol: effects of exercise booster sessions on preservation of exercise-induced adaptations in persons with multiple sclerosis, a multicentre randomised controlled trial-the MS BOOSTER trial.
Taul-Madsen L, Hvid LG, Sellebjerg F, Christensen JR, Ratzer R, Sejbæk T, Svendsen KB, Papp V, Højsgaard Chow H, Lundbye-Jensen J, Dawes H, Dalgas U. Taul-Madsen L, et al. Among authors: hojsgaard chow h. BMJ Open. 2024 Aug 17;14(8):e085241. doi: 10.1136/bmjopen-2024-085241. BMJ Open. 2024. PMID: 39153792 Free PMC article.
Age-corrected neurofilament light chain ratio decreases but does not predict relapse in highly active multiple sclerosis patients initiating natalizumab treatment.
Højsgaard Chow H, Petersen ER, Olsson A, Hejgaard Laursen J, Bredahl Hansen M, Oturai AB, Soelberg Sørensen P, Bach Søndergaard H, Sellebjerg F. Højsgaard Chow H, et al. Mult Scler Relat Disord. 2024 Aug;88:105701. doi: 10.1016/j.msard.2024.105701. Epub 2024 Jun 12. Mult Scler Relat Disord. 2024. PMID: 38889559 Free article.
Dimethyl fumarate treatment of primary progressive multiple sclerosis: results of an open-label extension study.
Højsgaard Chow H, Talbot J, Lundell H, Marstrand L, Gøbel Madsen C, Bach Søndergaard H, Bredahl Hansen M, Solberg Sørensen P, Siebner HR, Sellebjerg F. Højsgaard Chow H, et al. Mult Scler Relat Disord. 2023 Feb;70:104458. doi: 10.1016/j.msard.2022.104458. Epub 2022 Dec 9. Mult Scler Relat Disord. 2023. PMID: 36586351 Free article. Clinical Trial.
Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosis.
Talbot J, Højsgaard Chow H, Mahler M, Buhelt S, Holm Hansen R, Lundell H, Vinther-Jensen T, Hellem MNN, Nielsen JE, Siebner HR, von Essen MR, Sellebjerg F. Talbot J, et al. Among authors: hojsgaard chow h. Mult Scler Relat Disord. 2022 Dec;68:104209. doi: 10.1016/j.msard.2022.104209. Epub 2022 Oct 3. Mult Scler Relat Disord. 2022. PMID: 36257152 Free article. Clinical Trial.
Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis.
Holm Hansen R, Talbot J, Højsgaard Chow H, Bredahl Hansen M, Buhelt S, Herich S, Schwab N, Hellem MNN, Nielsen JE, Sellebjerg F, von Essen MR. Holm Hansen R, et al. Among authors: hojsgaard chow h. Neurol Neuroimmunol Neuroinflamm. 2022 Jul 14;9(5):e200009. doi: 10.1212/NXI.0000000000200009. Print 2022 Sep. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35835563 Free PMC article.
Peripheral helper T cells in the pathogenesis of multiple sclerosis.
Holm Hansen R, Højsgaard Chow H, Talbot J, Buhelt S, Nickelsen Hellem MN, Nielsen JE, Sellebjerg FT, von Essen MR. Holm Hansen R, et al. Among authors: hojsgaard chow h. Mult Scler. 2022 Aug;28(9):1340-1350. doi: 10.1177/13524585211067696. Epub 2022 Feb 3. Mult Scler. 2022. PMID: 35112578
Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial.
Højsgaard Chow H, Talbot J, Lundell H, Gøbel Madsen C, Marstrand L, Lange T, Mahler MR, Buhelt S, Holm Hansen R, Blinkenberg M, Romme Christensen J, Soelberg Sørensen P, Rode von Essen M, Siebner HR, Sellebjerg F. Højsgaard Chow H, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Aug 24;8(5):e1037. doi: 10.1212/NXI.0000000000001037. Print 2021 Sep. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34429340 Free PMC article. Clinical Trial.
11 results